Literature DB >> 26087697

The Novel KV7.2/KV7.3 Channel Opener ICA-069673 Reveals Subtype-Specific Functional Roles in Guinea Pig Detrusor Smooth Muscle Excitability and Contractility.

Aaron Provence1, John Malysz1, Georgi V Petkov2.   

Abstract

The physiologic roles of voltage-gated KV7 channel subtypes (KV7.1-KV7.5) in detrusor smooth muscle (DSM) are poorly understood. Here, we sought to elucidate the functional roles of KV7.2/KV7.3 channels in guinea pig DSM excitability and contractility using the novel KV7.2/KV7.3 channel activator ICA-069673 [N-(2-chloro-5-pyrimidinyl)-3,4-difluorobenzamide]. We employed a multilevel experimental approach using Western blot analysis, immunocytochemistry, isometric DSM tension recordings, fluorescence Ca(2+) imaging, and perforated whole-cell patch-clamp electrophysiology. Western blot experiments revealed the protein expression of KV7.2 and KV7.3 channel subunits in DSM tissue. In isolated DSM cells, immunocytochemistry with confocal microscopy further confirmed protein expression for KV7.2 and KV7.3 channel subunits, where they localize within the vicinity of the cell membrane. ICA-069673 inhibited spontaneous phasic, pharmacologically induced, and nerve-evoked contractions in DSM isolated strips in a concentration-dependent manner. The inhibitory effects of ICA-069673 on DSM spontaneous phasic and tonic contractions were abolished in the presence of the KV7 channel inhibitor XE991 [10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone dihydrochloride]. Under conditions of elevated extracellular K(+) (60 mM), the effects of ICA-069673 on DSM tonic contractions were significantly attenuated. ICA-069673 decreased the global intracellular Ca(2+) concentration in DSM cells, an effect blocked by the L-type Ca(2+) channel inhibitor nifedipine. ICA-069673 hyperpolarized the membrane potential and inhibited spontaneous action potentials of isolated DSM cells, effects that were blocked in the presence of XE991. In conclusion, using the novel KV7.2/KV7.3 channel activator ICA-069673, this study provides strong evidence for a critical role for the KV7.2- and KV7.3-containing channels in DSM function at both cellular and tissue levels.
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26087697      PMCID: PMC4538873          DOI: 10.1124/jpet.115.225268

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  37 in total

1.  Kv7 potassium channels in airway smooth muscle cells: signal transduction intermediates and pharmacological targets for bronchodilator therapy.

Authors:  Lioubov I Brueggemann; Priyanka P Kakad; Robert B Love; Julian Solway; Maria L Dowell; Leanne L Cribbs; Kenneth L Byron
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-30       Impact factor: 5.464

2.  Molecular and functional characterization of Kv7 K+ channel in murine gastrointestinal smooth muscles.

Authors:  Thomas A Jepps; Iain A Greenwood; James D Moffatt; Kenton M Sanders; Susumu Ohya
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-23       Impact factor: 4.052

Review 3.  The urinary safety profile and secondary renal effects of retigabine (ezogabine): a first-in-class antiepileptic drug that targets KCNQ (K(v)7) potassium channels.

Authors:  Neil Brickel; Paul Gandhi; Kevan VanLandingham; Janet Hammond; Sarah DeRossett
Journal:  Epilepsia       Date:  2012-03-16       Impact factor: 5.864

4.  Vasorelaxant effects of novel Kv 7.4 channel enhancers ML213 and NS15370.

Authors:  T A Jepps; B H Bentzen; J B Stott; O V Povstyan; K Sivaloganathan; W Dalby-Brown; I A Greenwood
Journal:  Br J Pharmacol       Date:  2014-08-14       Impact factor: 8.739

5.  N-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of Epilepsy.

Authors:  George Amato; Rosemarie Roeloffs; Greg C Rigdon; Brett Antonio; Theresa Mersch; Grant McNaughton-Smith; Alan D Wickenden; Paul Fritch; Mark J Suto
Journal:  ACS Med Chem Lett       Date:  2011-03-31       Impact factor: 4.345

Review 6.  The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy.

Authors:  Martin J Gunthorpe; Charles H Large; Raman Sankar
Journal:  Epilepsia       Date:  2012-01-05       Impact factor: 5.864

7.  Novel role for the transient potential receptor melastatin 4 channel in guinea pig detrusor smooth muscle physiology.

Authors:  Amy C Smith; Kiril L Hristov; Qiuping Cheng; Wenkuan Xin; Shankar P Parajuli; Scott Earley; John Malysz; Georgi V Petkov
Journal:  Am J Physiol Cell Physiol       Date:  2013-01-09       Impact factor: 4.249

Review 8.  Driving with no brakes: molecular pathophysiology of Kv7 potassium channels.

Authors:  Maria Virginia Soldovieri; Francesco Miceli; Maurizio Taglialatela
Journal:  Physiology (Bethesda)       Date:  2011-10

9.  Molecular expression and pharmacological evidence for a functional role of kv7 channel subtypes in Guinea pig urinary bladder smooth muscle.

Authors:  Serge A Y Afeli; John Malysz; Georgi V Petkov
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

10.  Functional expression of KCNQ (Kv7) channels in guinea pig bladder smooth muscle and their contribution to spontaneous activity.

Authors:  U A Anderson; C Carson; L Johnston; S Joshi; A M Gurney; K D McCloskey
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

View more
  7 in total

1.  KV7 Channel Pharmacological Activation by the Novel Activator ML213: Role for Heteromeric KV7.4/KV7.5 Channels in Guinea Pig Detrusor Smooth Muscle Function.

Authors:  Aaron Provence; Damiano Angoli; Georgi V Petkov
Journal:  J Pharmacol Exp Ther       Date:  2017-10-30       Impact factor: 4.030

2.  The KV 7 channel activator retigabine suppresses mouse urinary bladder afferent nerve activity without affecting detrusor smooth muscle K+ channel currents.

Authors:  Nathan R Tykocki; Thomas J Heppner; Thomas Dalsgaard; Adrian D Bonev; Mark T Nelson
Journal:  J Physiol       Date:  2018-12-26       Impact factor: 5.182

3.  TRPM4 channel inhibitors 9-phenanthrol and glibenclamide differentially decrease guinea pig detrusor smooth muscle whole-cell cation currents and phasic contractions.

Authors:  John Malysz; Sarah E Maxwell; Viktor Yarotskyy; Georgi V Petkov
Journal:  Am J Physiol Cell Physiol       Date:  2019-12-18       Impact factor: 4.249

Review 4.  Urinary bladder smooth muscle ion channels: expression, function, and regulation in health and disease.

Authors:  John Malysz; Georgi V Petkov
Journal:  Am J Physiol Renal Physiol       Date:  2020-07-06

Review 5.  Chemical modulation of Kv7 potassium channels.

Authors:  Matteo Borgini; Pravat Mondal; Ruiting Liu; Peter Wipf
Journal:  RSC Med Chem       Date:  2021-01-14

6.  Kv7 Channels and Excitability Disorders.

Authors:  Frederick Jones; Nikita Gamper; Haixia Gao
Journal:  Handb Exp Pharmacol       Date:  2021

7.  Age-dependent decrease in TRPM4 channel expression but not trafficking alters urinary bladder smooth muscle contractility.

Authors:  Sarah E Maxwell; M Dennis Leo; John Malysz; Georgi V Petkov
Journal:  Physiol Rep       Date:  2021-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.